Identification and definition of asthma-COPD overlap: The CanCOLD study.

Clicks: 350
ID: 96648
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #7 of 121 articles by views in respirology (carlton, vic)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 121 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Lack of consensus on diagnosis of ACO limits our understanding of the impact, management and outcomes of ACO. The present observational study aims to describe the prevalence, clinical characteristics and course of individuals with ACO based on various definitions used in clinical practice.We included individuals with COPD from the prospective, multisite CanCOLD study and defined subjects with ACO using seven definitions commonly used in the literature.Data including questionnaires, lung function and CT scans were analysed from 522 individuals with COPD who were randomly recruited from the population. Among them, 264 fulfilled at least one of the seven definitions of ACO. Prevalence of ACO varied from 3.8% to 31%. Regardless of the definition, individuals with ACO had worse outcomes (lung function and higher percentage of fast decliners, symptoms and exacerbations, health-related quality of life and comorbidities) than the remaining patients with COPD. Conversely, patients with non-ACO had higher emphysema and bronchiolitis scores. The three definitions that included atopy and/or physician diagnosis of asthma identified subjects who differed significantly from patients with COPD. The two ACO definitions with post-bronchodilator reversibility were concordant with COPD and were the least stable, with less than 50% of the patients from each group maintaining reversibility over visits.Atopy and physician-diagnosed asthma are more distinguishing characteristics to identify ACO. This finding needs to be validated using measures of airway inflammation and other specific biomarkers.
Reference Key
barrecheguren2020identificationrespirology Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Barrecheguren, Miriam;Pinto, Lancelot;Mostafavi-Pour-Manshadi, Seyed-Mohammad-Yousof;Tan, Wan C;Li, Pei Z;Aaron, Shawn D;Benedetti, Andrea;Chapman, Kenneth R;Walker, Brandie;Fitzgerald, J Mark;Hernandez, Paul;Maltais, François;Marciniuk, Darcy D;O'Donnell, Denis E;Sin, Don D;Bourbeau, Jean;, ;
Journal respirology (carlton, vic)
Year 2020
DOI
10.1111/resp.13780
URL
Keywords
outcomes phenotype features asthma and chronic obstructive pulmonary disease overlap

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.